<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Infection and Immunity</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Infection and Immunity</journal-title><trans-title-group xml:lang="ru"><trans-title>Инфекция и иммунитет</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2220-7619</issn><issn publication-format="electronic">2313-7398</issn><publisher><publisher-name xml:lang="en">SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">28</article-id><article-id pub-id-type="doi">10.15789/2220-7619-2011-1-59-66</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">OPPORTUNITIES OF FLOW CYTOMETRY IN DIAGNOSTICS OF INFECTIOUS DISEASES. PART 1</article-title><trans-title-group xml:lang="ru"><trans-title>ВОЗМОЖНОСТИ ПРОТОЧНОЙ ЦИТОФЛЮОРИМЕТРИИ В ДИАГНОСТИКЕ ИНФЕКЦИОННЫХ ЗАБОЛЕВАНИЙ. Часть 1</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Khaidukov</surname><given-names>S. V.</given-names></name><name xml:lang="ru"><surname>Хайдуков</surname><given-names>С. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>д.б.н., зав. лабораторией физиологии и патологии иммунной системы</p><p>117997, Москва, ул. Миклухо-Маклая, 16/10</p></bio><email>khsv@mail.ibch.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zurochka</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Зурочка</surname><given-names>А. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>khsv@mail.ibch.ru</email><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">Институт биоорганической химии им. акад. М.М. Шемякина и Ю.А. Овчинникова РАН, Москва&#13;
&#13;
ФГУ Федеральный Научно-Клинический Центр детской гематологии, онкологии и иммунологии РОСЗДРАВА, Москва</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">Институт иммунологии и физиологии УрО РАН, г. Екатеринбург</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2011-06-24" publication-format="electronic"><day>24</day><month>06</month><year>2011</year></pub-date><volume>1</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>59</fpage><lpage>66</lpage><history><date date-type="received" iso-8601-date="2014-06-25"><day>25</day><month>06</month><year>2014</year></date><date date-type="accepted" iso-8601-date="2014-06-25"><day>25</day><month>06</month><year>2014</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2014, Khaidukov S.V., Zurochka A.V.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2014, Хайдуков С.В., Зурочка А.В.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="en">Khaidukov S.V., Zurochka A.V.</copyright-holder><copyright-holder xml:lang="ru">Хайдуков С.В., Зурочка А.В.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://iimmun.ru/iimm/article/view/28">https://iimmun.ru/iimm/article/view/28</self-uri><abstract xml:lang="en"><p><bold>Abstract.</bold> Development of a modern medical science demands more thorough and deeper approach to diagnostics of diseases. New diagnostic technologies for these investigations are necessary and flow cytometry is such technology. Modern achievements in the field of fluorescent dyes, development of laser and computer technologies, have led to wide use of the given technology in medical practice. Infectious immunology is not exception. Cytokines production analysis at tuberculosis, HLA-DR expression changes for monocytes and CD64 for granulocytes at sepsis are the important diagnostic attributes. Flow cytometry offers new approaches to early and faster diagnostics of infringements of immune system at tuberculosis and sepsis, allows supervising development of these pathologies more effectively and estimate efficiency of therapy.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Резюме.</bold> Развитие современной медицинской науки требует более досконального и более глубокого подхода к диагностике заболеваний, и как следствие этого возникает необходимость в применении новых диагностических технологий. Проточная цитофлюориметрия является такой технологией. Использование современных достижений в области флуоресцентных красителей, развитие лазерных и компьютерных технологий, привели к широкому использованию данной технологии в медицинской практике. Не является исключением и инфекционная иммунология. Использование анализа продукции цитокинов при туберкулезе и изменение экспрессии HLA-DR на моноцитах и CD64 на гранулоцитах при сепсисе являются важными диагностическими признаками. Проточная цитофлюориметрия предлагает новые подходы к ранней и более быстрой диагностике нарушений иммунной системы при туберкулезе и сепсисе, позволяет более эффективно контролировать развитие этих патологий и оценить эффективность терапии.</p></trans-abstract><kwd-group xml:lang="en"><kwd>flow cytometry</kwd><kwd>tuberculosis</kwd><kwd>CD27</kwd><kwd>sepsis</kwd><kwd>monocytes</kwd><kwd>neutrophils</kwd><kwd>CD64</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>проточная цитометрия</kwd><kwd>туберкулез</kwd><kwd>CD27</kwd><kwd>сепсис</kwd><kwd>моноциты</kwd><kwd>нейтрофилы</kwd><kwd>CD64</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>1.	Зурочка А.В., Котляров А.Н., Кувайцев М.В., Квятковская С.В., Зурочка В.А., Рябова Л.В., Хайдуков С.В. Изменения Экспрессии HLA-DR-антигенов на моноцитах у детей и ее клиническая значимость при сепсисе // Медицинская иммунология. — 2008. — Т. 10, № 4–5. — С. 379–388.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>2.	Хайдуков С.В., Зурочка А.В. Проточная цитометрия как современный метод анализа в биологии и медицине // Медицинская иммунология. — 2007. — Т. 9, № 4–5. — С. 373–378.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>3.	Хайдуков С.В. Подходы к стандартизации метода проточной цитометрии для иммунофенотипирования. Настройка цитометров и подготовка протоколов для анализа // Медицинская иммунология. — 2007. — Т. 9, № 6. — С. 569–574.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>4.	Asadullah K., Woiciechowsky C., Docke W.D., Egerer K., Kox W., Volgel S., Sterry W., Volk H.D. Very low monocytic HLA-DR expression indicates high risk of infection — immunomonitoring for patients after neurosurgery and patients during high dose steroid therapy // Eur. J. Emerg. Med. — 1995. — Vol. 2. — P. 184 –190.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>5.	Bizzarro M.J., Raskind C., Baltimore R.S., Gallagher P.G. Seventy five years of neonatal sepsis at Yale: 1928–2003 // Pediatrics. — 2005. — Vol. 116. — P. 595–602.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>6.	Boelens P.G., Houdijk A.P., Fonk J.C., Nijveldt R.J., Ferwerda C.C., Von Blomberg-Van Der Flier B.M., Thijs L.G., Haarman H.J., Puyana J.C., Van Leeuwen P.A. Glutamine-enriched enteral nutrition increases HLA-DR expression on monocytes of trauma patients // J. Nutr. — 2002. — Vol. 132, N 9. — P. 2580–2586.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>7.	Clark R.H., Bloom B.T., Spitzer A.R., Gerstmann D.R. Empiric use of ampicillin and cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for sepsis is associated with an increased risk of neonatal death // Pediatrics. — 2006. — Vol. 117. — P. 67–74.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>8.	Cohen G.B., Gandhi R.T., Davis D.M., Mandelboim O., Chen B.K., Strominger J.L., Baltimore D. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells // Immunity. — 1999. — Vol. 10. — P. 661– 671.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>9.	Collins K.L., Chen B.K., Kalams S.A., Walker B.D., Baltimore D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes // Nature. — 1998. — Vol. 391. — P. 397–401.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>10.	Daftary A., Padayatchi N., Padilla M. HIV testing and disclosure: a qualitative analysis of TB patients in South Africa // AIDS Care. — 2007. — Vol. 19. — P. 572–577.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>11.	Ditschkowski M., Kreuzfelder E., Rebmann V., Ferencik S., Majetschak M., Schmid E.N., Obertacke U., Hirche H., Schade U.F., Grosse-Wilde H. HLA-DR expression and soluble HLA-DR levels in septic patients after trauma // Ann. Surg. — 1999. — Vol. 229, N 2. — P. 24 6 –254.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>12.	Docke W.D., Hoflich C., Davis K.A., Rottgers K., Meisel C., Kiefer P., Weber S.U., Hedwig-Geissing M., Kreuzfelder E., Tschentscher P., Nebe T., Engel A., Monneret G., Spittler A., Schmolke K., Reinke P., Volk H.D., Kunz D. Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression: a multicenter standardized study // Clin. Chem. — 2005. — Vol. 51, N 12. — P. 2341–2347.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>13.	Fine P.E., Rodrigues L.C. Modern vaccines. Mycobacterial diseases // Lancet. — 1990. — Vol. 335. —P. 1016 –1020.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>14.	Flynn J.L., Chan J. Immunology of tuberculosis // Annu. Rev. Immunol. — 2001. — Vol. 19. — P. 93–129.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>15.	Fumeaux T., Pugin J. Role of interleukin-10 in the intracellular sequestration of human leukocyte antigen-DR in monocytes during septic shock // Am. J. Respir. Crit. Care. Med. — 2002. — Vol. 166, N 11. — P. 1475–1482.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>16.	Garcia P., Llano M., de Heredia A.B., Willberg C.B., Caparrós E., Aparicio P., Braud V.M., López-Botet M. Human T cell receptor-mediated recognition of HLA-E // Eur. J. Immunol. — 2002. — Vol. 32. — P. 936—944.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>17.	Gerdes J.S. Clinicopathologic approach to the diagnosis of neonatal sepsis // Clin. Perinatol. — 1991. — Vol. 18. — P. 361–381.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>18.	Gonzalez B.E., Mercado C.K., Johnson L., Brodsky N.L., Bhandari V. Early markers of late-onset sepsis in premature neonates: clinical, hematological and cytokine profile // J. Perinat. Med. — 2003. — Vol. 31. — P. 60–68.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>19.	Grimsley C., Ober C. Population genetic studies of HLA-E: evidence for selection // Hum. Immunol. — 1997. — Vol. 52. — P. 33–40.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>20.	Guillou P.J. Biological variation in the development of sepsis after surgery or trauma // Lancet. — 1993. — Vol. 342. — P. 217–220.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>21.	Haveman J.W., Berg A.P. van den, Berk J.M. van den, Mesander G., Slooff M.J., Leij L.H. de, The T.H. Low HLA-DR expression on peripheral blood monocytes predicts bacterial sepsis after liver transplantation: relation with prednisolone intake // Transpl. Infect. Dis. — 1999. — Vol. 1, N 3. — P. 146–152.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>22.	Heinzel A.S., Grotzke J.E., Lines R.A., Lewinsohn D.A., McNabb A.L., Streblow D.N., Braud V.M., Grieser H.J., Belisle J.T., Lewinsohn D.M. HLA-E-dependent presentation of Mtb-derived antigen to human CD8+T cells // J. Exp. Med. — 2002. — Vol. 196. — P. 1473–1481.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>23.	Hellberg S., Sjostrom M., Skagerberg B., Wold S. Peptide quantitative structure-activity relationships, a multivariate approach // J. Med. Chem. — 1987. — Vol. 30. — P. 1126–1135.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>24.	Hershman M.J., Cheadle W.G., Wellhausen S.R., Davidson P.F., Polk S.C. Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient // Br. J. Surg. — 1990. — Vol. 77. — P. 204–207.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>25.	Hoffman J.A., Weinberg K.I., Azen C.G., Horn M.V., Dukes L., Starnes V.A., Woo M.S. Human leukocyte antigen-DR expression on peripheral blood monocytes and the risk of pneumonia in pediatric lung transplant recipients // Transpl. Infect. Dis. — 2004. — Vol. 6. — P. 147–155.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>26.	Hoffmeyer F., Witte K., Schmidt R.E. The high-affinity FcγRI on PMN: regulation of expression and signal transduction // Immunology. — 1997 — Vol. 92. — P. 54 4 –552.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>27.	Hurst M.K., Yoder B.A. Detection of bacteremia in young infants: is 48 hours adequate? // Pediatr. Infect. Dis. J. — 1995. — Vol. 14. — P. 711–713.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>28.	Jardine L., Davies M.W., Faoagali J. Incubation time required for neonatal blood cultures to become positive // J. Paediatr. Child. Health. — 2006. — Vol. 42. — P. 797–802.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>29.	Kaufmann S.H. Envisioning future strategies for vaccination against tuberculosis // Nat. Rev. Immunol. — 2006. — Vol. 6. — P. 699–704.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>30.	Kawasaki T., Ogata M., Kawasaki C., Tomihisa T., Okamoto K., Shigematsu A. Surgical stress induces endotoxin hyporesponsiveness and an early decrease of monocyte mCD14 and HLA-DR expression during surgery // Anesth. Analg. — 2001. — Vol. 92, N 5. — P. 1322–1326.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>31.	Khaidukov S.V., Komaleva R.L., Nesmeyanov V.A. N-acetylglucosamine-containing muramyl peptides directly affect macrophages // Int. J. Immunopharmacol. — 1995. — Vol. 17, N 11. — P. 903–911.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>32.	Khassawneh M., Hayajneh W.A., Kofahi H., Khader Y., Amarin Z., Daoud A. Diagnostic markers for neonatal sepsis: comparing C-reactive protein, interleukin-6 and immunoglobulin M // Scand. J. Immunol. — 2007. — Vol. 65. — P. 171–175.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>33.	Kox W.J., Volk T., Kox S.N., Volk H.D. Immunomodulatory therapies in sepsis // Int. Care. Med. — 2000. — Vol. 26. — P. 124–128.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>34.	Kristiansen M., Graversen J.H., Jacobsen C., Sonne O., Hoffman H.J., Law S.K., Moestrup S.K. Identification of the haemoglobin scavenger receptor // Nature. — 2001. — Vol. 409, N 6817. — P. 198–201.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>35.	Kunz D., Pross M., Lippert H., Konig W., Manger T. Diagnostic relevance of procalcitonin, IL-6 and cellular immune status in the early phase after liver transplantation // Transplant. Proc. — 1998. — Vol. 30. — P. 23 –24.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>36.	Lawn J.E., Wilczynska-Ketende K., Cousens S.N. Estimating the causes of 4 million neonatal deaths in the year 2000 // Int. J. Epidemiol. — 2006. — Vol. 35. —P. 70 6 –718.</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>37.	Le Tulzo Y., Pangault C., Amiot L., Guilloux V., Tribut O., Arvieux C., Camus C., Fauchet R., Thomas R., Drénou B. Monocyte human leukocyte antigen-DR transcriptional downregulation by cortisol during septic shock // Am. J. Respir. Crit. Care. Med. — 2004. — Vol. 169, N 10. — P. 114 4 –1151.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>38.	Lin R.Y., Astiz M.E., Saxon J.C., Rackow E.C. Altered leukocyte immunophenotypes in septic shock. Studies of HLA-DR, CD11b, CD14, and IL-2R expression // Chest. — 1993. — Vol. 104, N 3. — P. 847–853.</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>39.	Lyadova I.V., Oberdorf S., Kapina M.A., Apt A.S., Swain S.L., Sayles P.C. CD4 T cells producing IFN-gamma in the lungs of mice challenged with mycobacteria express a CD27-negative phenotype // Clin. Exp. Immunol. — 2004. — Vol. 138. — P. 21–29.</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>40.	Mehr S., Doyle L.W. Cytokines as markers of bacterial sepsis in newborn infants: a review // Pediatr. Infect. Dis J. — 2000. — Vol. 19. — P. 879–887.</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>41.	Monneret G., Elmenkouri N., Bohe J., Debard A.L., Gutowski M.C., Bienvenu J., Lepape A. Analytical requirements for measuring monocytic human lymphocyte antigen DR by flow cytometry: application to the monitoring of patients with septic shock // Clin. Chem. — 2002. — Vol. 48, N 9. — P. 1589–1592.</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>42.	Ng P.C., Lam H.S. Diagnostic markers for neonatal sepsis // Curr. Opin. Pediatr. — 2006. — Vol. 18. — P. 125–131.</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>43.	Ng P.C., Li G., Chui K.M., Chu W.C., Li K., Wong R.P., Fok T.F. Quantitative measurement of monocyte HLA-DR expression in the identification of early-onset neonatal infection // Biol. Neonate. — 2006. — Vol. 89, N 2. — P. 75–81.</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>44.	Noursadeghi M., Katz D.R., Miller R.F. HIV-1 infection of mononuclear phagocytic cells: the case for bacterial innate immune deficiency in AIDS // Lancet. Infect. Dis. — 2006. — Vol. 6. — P. 794–804.</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>45.	Ottenhoff T.H. Overcoming the global crisis: ‘‘yes, we can’’, but also for TB …? // Eur. J. Immunol. — 2009. — Vol. 39. — P. 2014–2020.</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>46.	Pietra G., Romagnani C., Falco M., Vitale M., Castriconi R., Pende D., Millo E., Anfossi S., Biassoni R., Moretta L., Mingari M.C. The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta-mediated recognition // Eur. J. Immunol. — 2001. — Vol. 31. — P. 3687–3693.</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>47.	Pitton C., Fitting C., Deuren M. van, Meer J.W. van der, Cavaillon J.M. Different regulation of TNF-α and IL-1ra synthesis in LPS-tolerant human monocytes // Prog. Clin. Biol. Res. — 1995. — Vol. 392. — P. 523–528.</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>48.	Richter A., Nebe T., Wendl K., Schuster K., Klaebisch G., Quintel M., Lorenz D., Post S., Trede M. HLA-DR Expression in acute pancreatitis // Eur. J. Surg. — 1999. — Vol. 165. — P. 947–951.</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>49.	Sachse C., Prigge M., Cramer G., Pallua N., Henkel E. Association between reduced human leukocyte antigen (HLA-DR) expression on blood monocytes and increased plasma level of interleuk in-10 in patients with severe bur ns // Clin. Chem. Lab. Med. — 1999. — Vol. 37. — P. 193–198.</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>50.	Sandberg M., Eriksson L., Jonsson J., Sjostrom M., Wold S. New chemical descriptors relevant for the design of biologically active peptides. A multivariate characterization of 87 amino acids // J. Med. Chem. — 1998. — Vol. 41. — P. 2481–2491.</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>51.	Spittler A., Winkler S., Gotzinger P., Oehler R., Willheim M., Tempfer C., Weigel G., Fugger R., Boltz-Nitulescu G., Roth E. Influence of glutamine on the phenotype and function of human monocytes // Blood. — 1995. — Vol. 86, N 4. — P. 1564–1569.</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>52.	Streitz M., Tesfa L., Yildirim V., Yahyazadeh A., Ulrichs T., Lenkei R., Quassem A., Liebetrau G., Nomura L., Maecker H., Volk H.D., Kern F. Loss of receptor on tuberculin-reactive T-cells marks active pulmonary tuberculosis // PloS. One. — 2007. — Vol. 2, N 1. — e735.</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>53.	Strohmeyer J.C., Blume C., Meisel C., Doecke W.D., Hummel M., Hoeflich C., Thiele K., Unbehaun A., Hetzer R., Volk H.D. Standardized immune monitoring for the prediction of infections after cardiopulmonary bypass surgery in risk patients // Cytometry. — 2003. — Vol. 53. — P. 54–62.</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>54.	Tschaikowsky K., Hedwig-Geissing M., Schiele A., Bremer F., Schywalsky M., Schuttler J. Coincidence of pro- and anti-inflammatory responses in the early phase of severe sepsis: longitudinal study of mononuclear histocompatibility leukocyte antigen DR expression, procalcitonin, C-reactive protein, and changes in T-cell subsets in septic and postoperative patients // Crit. Care. Med. — 2002. — Vol. 30. — P. 1015–1023.</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>55.	Turner D., Hammerman C., Rudensky B., Schlesinger Y., Schimmel M.S. The role of procalcitonin as a predictor of nosocomial sepsis in preterm infants // Acta. Paediatr. — 2006. — Vol. 95. — P. 1571–1576.</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>56.	Volk H.D., Lohmann T., Heym S., Golosubow A., Ruppe U., Reinke P. et al. Decrease of the proportion of HLA-DR-monocytes as prognostic parameter for the clinical outcome of septic disease // Immunotherapeutic prospects of infectious diseases; Masihi K.N., Lange W., eds. — Heidelberg: Springer Verlag, 1990. — P. 297–301.</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>57.	Whittaker E., Kampmann B. Perinatal tuberculosis: new challenges in the diagnosis and treatment of tuberculosis in infants and the newborn // Early. Hum. Dev. — 2008. — Vol. 84. — P. 795–799.</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>58.	Wolk K., Docke W.D., von Baehr R., Volk H.D., Sabat R. Comparison of monocyte functions after LPS- or IL-10-induced reorientation: importance in clinical immunoparalysis // Pathobiology. — 1999. — Vol. 67. — P. 253–256.</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation>59.	Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein // Science. — 1990. — Vol. 249, N 4975. — P. 1431–1433.</mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation>60.	Zuwała-Jagiełło J. Haemoglobin scavenger receptor: function in relation to disease // Acta. Biochim. Pol. — 2006. — Vol. 53, N 2. — P. 257–268.</mixed-citation></ref></ref-list></back></article>
